Pharma Radar
Tracking what matters in HEOR, market access, and pharma consulting for your career success
NEWEST
NICE
+1
NICE Conference 2026: What Was Said, What It Means, and Whether to Be Optimistic
Apr 6, 2026
•
5 min read
ALL POSTS
Explore our archive of posts.
TAGS
Professional Development
Strategies, mindsets, and habits for growing your skills and advancing your career across pharma, biotech, and the broader life sciences industry.
Pharma Leadership
Perspectives on what it takes to lead effectively in the pharmaceutical industry — from managing teams and navigating organisational culture to building credibility at the top.
Interview Tips
How to prepare for and perform in interviews — from common mistakes to what hiring managers actually look for.
Career Advice
Practical guidance for navigating and advancing your career in pharma, biotech, and health sciences.
Pharma Recruitment
Insights into how hiring works in the pharmaceutical and life sciences industry — from recruiter perspectives to candidate strategies.
Life Sciences Jobs
Roles, opportunities, and trends shaping the job market across pharma, biotech, and related health science sectors.
Tools & Productivity
Software recommendations, workflow tips, and the tech that powers my day-to-day.
Market Access
How medicines move from regulatory approval to patient availability. Covers pricing, reimbursement, HTA processes, and the strategic decisions that determine whether a drug actually reaches the people it was developed for.
Clinical Outcome Assessments (COA)
The full toolbox for measuring treatment benefit, including patient-reported, clinician-reported, observer-reported, and performance-based outcomes. PROs are one part of the wider COA landscape.
Pharma Consulting
Strategic advisory services helping pharmaceutical companies navigate market access, pricing strategy, health economics, and regulatory pathways to maximize product value and commercial success.
NICE
UK health technology assessment body evaluating clinical and cost-effectiveness of treatments for NHS adoption.
Systematic Literature Review
Structured methods for identifying, evaluating, and synthesizing published research to answer specific clinical or economic questions—essential for HTA submissions and evidence-based decision-making.
Outcomes Research
Research focused on understanding the real-world benefits, risks, and value of healthcare interventions.
Drug Pricing
How medicine prices are set, justified, and negotiated—and the consequences for patients and health systems.
Patient-Reported Outcomes (PRO)
Outcomes reported directly by patients that reflect symptoms, functioning, and quality of life. PROs capture what treatments feel like in real life — not just what they do clinically.
Real-World Evidence
Evidence generated from routine clinical practice, such as claims data and electronic health records, rather than clinical trials.
Pharmaceutical Policy
The rules, incentives, and governance shaping how medicines are developed, priced, and used in healthcare systems.
Health Economics
The study of how healthcare resources are allocated, including costs, value, and trade-offs in medical decision-making.
Drug Regulation
How medicines are evaluated, approved, and monitored by regulatory authorities such as the FDA and EMA.
Evidence-Based Medicine
Using the best available scientific evidence to guide clinical decisions and healthcare policy.
Apr 6, 2026
•
5 min read
NICE Conference 2026: What Was Said, What It Means, and Whether to Be Optimistic
A new chief exec, a QALY debate that won't go away, and the moment NICE and the MHRA finally got in the same room.
NICE
+1
